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940Objective: The study’s objectives were to evaluate results and identify predictors of hospital and mid-term mor-
tality after primary isolated aortic valve replacement; compare early and mid-term survival of patients aged more
than 80 years or less than 80 years; and assess the effectiveness of the logistic European System for Cardiac
Operative Risk Evaluation in predicting the risk for hospital mortality in octogenarians with a logistic European
System for Cardiac Operative Risk Evaluation greater than 15% who are undergoing aortic valve replacement.
Methods: Data from 2256 patients undergoing primary isolated aortic valve replacement between January 2003
and December 2007 were prospectively collected in a Regional Registry (Regione Emilia Romagna Interventi
Cardiochirurgia) and analyzed to estimate hospital and mid-term results.
Results: Overall hospital mortality was 2.2%. By multivariate analysis, New York Heart Association III and IV,
Canadian Cardiovascular Society III and IV, pulmonary artery pressure greater than 60 mm Hg, dialysis, central
neurologic dysfunction, and severe chronic obstructive pulmonary disease emerged as independent predictors of
hospital mortality. At 3 years, the survival was 89.3%. The same predictors of hospital mortality plus ejection
fraction of 30% to 50% and age more than 80 years emerged as independent risk factors for 3-year mortality.
Compared with younger patients, octogenarians had a higher hospital mortality rate (3.72% vs 1.81%;
P ¼ .0143) and a reduced 3-year survival (82.3% vs 91.3%; P< .001). Three-year survival of octogenarians
was comparable to the expected survival of an age- and gender-matched regional population (P¼ .157). The ob-
served mortality rate in octogenarians with a logistic European System for Cardiac Operative Risk Evaluation
greater than 15% (mean: 22.4%) was 7% (P< .001).
Conclusions: This study provides contemporary data on the characteristics and outcome of patients undergoing
first-time isolated aortic valve replacement. (J Thorac Cardiovasc Surg 2011;141:940-7)During the last few years, advances in perioperative man-
agement and increased life expectancy have dramatically
changed the characteristics of patients who are referred for
aortic valve replacement. Octogenarians and high-risk
patients who were contraindicated for surgery in the past
currently represent a considerable portion of daily surgical
activity, with increased survival and functional benefits
being reported afterward.1-3
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The Journal of Thoracic and Cardiovascular Surgaortic valve stenosis are considered inoperable because of
advanced age or a high-risk profile and are not referred for sur-
gery. This has triggered the development of less-invasive
transcatheter techniques for aortic valve implantation with ex-
pected benefits in terms of mortality, postoperative complica-
tions, and social costs. The correct and well-calibrated
prediction of the operative risk by different risk models clearly
plays a central role in the decision-making process for refer-
ring patients to transcatheter aortic valve implantation rather
than conventional aortic valve replacement.6 In particular,
a logistic European System for Cardiac Operative Risk Eval-
uation (euroSCORE) greater than 15% to 20% is considered
as the cutoff value to refer patients for less-invasive transcath-
eter aortic valve procedures.7,8
The present study analyzed a series of 2256 patients un-
dergoing a first-time isolated aortic valve replacement be-
tween 2003 and 2007 aiming to (1) represent clinical
characteristics of contemporary patients referred for aortic
valve surgery; (2) estimate short- and mid-term survivals;
(3) identify risk factors for hospital and mid-term mortality;
(4) compare outcome of octogenarians versus younger pa-
tients; and (5) compare predicted (logistic euroSCORE)
and observed mortality in patients undergoing aortic valveery c April 2011
Abbreviations and Acronyms
CI ¼ confidence interval
CCS ¼ Canadian Cardiovascular Society
COPD ¼ chronic obstructive pulmonary
disease
euroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
HR ¼ hazard ratio
NYHA ¼ New York Heart Association
OR ¼ odds ratio
Di Eusanio et al Acquired Cardiovascular Diseasereplacement with age greater than 80 years and logistic euro-
SCORE greater than 15%.A
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DMATERIALS AND METHODS
Data Source: The Regione Emilia Romagna
Interventi Cardiochirurgia Registry
The Regione Emilia Romagna Interventi Cardiochirurgia Registry is
a prospective regional database collecting preoperative, intraoperative,
and postoperative data from patients undergoing cardiac surgical procedures
in the 6 regional cardiac surgery departments (academic hospitals: n ¼ 2,
private hospitals: n ¼ 4). Between January 2003 and December 2007,
data from 22,490 cardiac surgical procedures in 22,236 patients were col-
lected. The Registry management is centralized: Every 3 months the re-
gional Cardiac Surgery Departments are required to dispatch the data to
the Regional Health Care Agency for quality/completeness control and to
monitor cardiac surgery results in the Emilia Romagna region (4 million
residents).
The selection of variables, shared by the 6 cardiac surgery departments,
is extrapolated from the database of the Italian Society for Cardiac Surgery.
The Regional Health Care Agency notifies the Registry of the occurrence of
all deaths in regional Registry patients. The present study was approved by
the review board of the regional health agency, and informed consent was
obtained from each patient.
Patients’ Profile
We analyzed data from 2256 Registry patients undergoing primary iso-
lated aortic valve replacement between January 1, 2003, and December 31,
2007. Variable and variables definitions are listed in the Appendix.
The mean age was 70.4  11.2 years (range, 21–91 years). Octogenar-
ians represented 19.1% (n¼ 430) of the entire cohort of patients. Indication
for surgery was severe aortic valve stenosis in 1093 patients (48.4%), severe
aortic valve insufficiency in 386 patients (17.1%), and combined severe le-
sions with predominant stenosis in 777 patients (34.5%).9
New York Heart Association (NYHA) class III and IV were documented
in 1117 patients (49.5%); an urgent procedure (within the same hospitaliza-
tion) was performed in 129 patients (5.7%), and an emergency procedure
(immediate) was performed in 14 patients (0.6%). Mean standard and logistic
euroSCOREs were 6.3% and 7.2%, respectively. A bioprosthesis was im-
planted in 1710 patients (75.8%) with a mean age of 70.4 8.6 years (range,
21–91 years). The mean age of patients receiving a mechanical prosthesis
(n ¼ 546; 24.2%) was 60.0  11.9 years (range, 24–90 years). Compared
with younger patients, octogenarians presented a higher-risk profile because
of a greater incidence of congestive heart failure (8.9% vs 5.0%; P<.001),
NYHA III and IV (58.1% vs 47.5%; P<.001), recent myocardial infarction
(4.4% vs 2.3%), previous coronary percutaneous coronary intervention
(7.2% vs 4.6%; P ¼ .035), hypertension (74.7% vs 69.1%; P ¼ .023),The Journal of Thoracic and Casevere chronic obstructive pulmonary disease (COPD) (7.4% vs 4.9%;
P¼ .03), extracardiac vasculopathy (26.3% vs 16.1%; P<.001), and cere-
brovascular disease (6.7% vs 3.7%; P¼ .004). A higher incidence of active
infective endocarditis was observed in patients younger than 80 years (3.3%
vs 1.1%; P ¼ .026). Mean standard and logistic euroSCOREs of the entire
cohort of patients were 6.3% and 7.2%, respectively. In the octogenarian
group, the mean standard and logistic euroSCOREs were 8.9 (P< .001)
and 13.1% (P< .001), respectively. Patients’ preoperative characteristics
are listed in Table 1. Complete (100%) survival data at follow-up were
obtained for the 1822 patients resident in the region (80.8%).
Statistical Analysis
Continuous variables are expressed as the mean  1 standard deviation,
and categoric variables are expressed as percentage. All preoperative and
intraoperative variables were first analyzed using univariate analysis (un-
paired 2-tailed t test, chi-square test, or Fisher’s exact test when appropriate)
to determine whether any single factor influenced hospital mortality. Vari-
ables that achieved P less than .05 in the univariate analysis were examined
using multivariate analysis by forward stepwise logistic regression to eval-
uate independent risk factors for hospital mortality. Survival curves (taking
into account perioperative deaths) were estimated at 1, 2, and 3 years using
the Kaplan–Meier method and compared using the log-rank test only in re-
gional patients. Including the dummy of the variable regional residence and
extra-regional residence in the logistic regression assessed the possible dif-
ference of risk for in-hospital mortality between regional inhabitants and
extra-regional inhabitants. For each patient, the corresponding average
age- and gender-matched annual mortality rates of the regional (Emilia Ro-
magna, Italy) general population were obtained. These data were taken from
the most recent regional life tables of 2006 provided by the Italian Statistical
Office. On the basis of these mortality data, the probability of cumulative
expected survival was determined for the beginning of each year, which
resulted in an expected survival curve. Thus, the log-rank test was used to
compare patients’ survival with the expected survival of the age- and
gender-matched 2006 regional population. Independent predictors of
3-year survival were determined with the Cox proportional hazards analysis,
and the proportional hazard assumption was assessed using the test of Harrel
and Lee, a variation of Schoenfeld residuals test. Statistical analysis was
performed using SAS 9.1 (SAS Institute Inc, Cary, NC).RESULTS
Early Mortality
Overall hospital mortality was 2.2% (29/2256). On uni-
variate analysis, age more than 80 years, emergency, shock,
NYHA class III to IV, Canadian Cardiovascular Society
(CCS) class III to IV, systolic pulmonary artery pressure
more than 60 mm Hg, creatinine more than 2 mg/dL, dialy-
sis, severe COPD, central neurologic dysfunction, cerebro-
vascular disease, and infective endocarditis emerged as
risk factors for hospital mortality. On multivariate analysis,
NYHA III–IV (odds ratio [OR] ¼ 1.9; 95% confidence
interval [CI], 1.0–3.7), CCS III–IV (OR ¼ 4.3; 95% CI,
1.8–10.2), pulmonary artery pressure greater than 60 mm
Hg (OR ¼ 5.2; 95% CI, 10–25.8), dialysis (OR ¼ 9.8;
95% CI, 2.4–47.5), central neurologic dysfunction
(OR ¼ 5.0; 95% CI, 1.1–5.9), and severe COPD
(OR¼ 2.6; 95% CI, 1.6–15.7) emerged as independent pre-
dictors of hospital mortality. Hospital mortality for patients
in NYHA class I–II and I was 1.2% and 0.8%, respectively.
Mean overall hospitalization time was 14.3  8.5 days with
an intensive care mean length of stay of 2.3  4.2 days.rdiovascular Surgery c Volume 141, Number 4 941
TABLE 1. Patients’ profile
Preoperative variables
All (N ¼ 2256) Age<80 y (N ¼ 1826) Age  80 y (N ¼ 430)
P valueNo. % No. % No. %
Age, y 70.4  11.2
Female 1090 48.3 806 44.1 284 66.0 <.0001
Body mass index  30 419 18.6 359 19.7 60 14.0 .0062
Emergency status 14 0.6 11 0.6 3 0.7 .8211
Urgency status 129 5.7 95 5.2 34 7.9 .0298
NYHA  3 1117 49.5 867 47.5 250 58.1 .0001
CCS  3 90 4.0 67 3.7 23 5.3 .1095
Congestive heart failure 129 5.7 91 5.0 38 8.9 .0018
Hemodynamic instability 11 0.5 9 0.5 2 0.5 .945
Cardiogenic shock 12 0.5 9 0.5 3 0.7 .5958
30%<FE%<50% 335 14.8 275 15.1 60 14.0 .5617
FE  30% 56 2.5 47 2.6 9 2.1 .5644
Pulmonary artery pressure>60 mm Hg 14 0.6 8 0.4 6 1.4 .023
Hypertension 1582 70.1 1261 69.1 321 74.7 .0231
Diabetes 321 14.2 261 14.3 60 14.0 .8527
Severe COPD 121 5.4 89 4.9 32 7.4 .0335
Creatinine  2 mg/dL 57 2.5 45 2.5 12 2.8 .6982
Dialysis 13 0.6 13 0.7 0 0.0 .0801
Cerebrovascular disease 29 1.3 3.7 29 6.7 .0045
Central neurologic dysfunction 32 1.4 24 1.3 8 1.9 .388
Peripheral neurologic dysfunction 27 1.2 20 1.1 7 1.6 .3589
Extracardiac vasculopathy 407 18.0 293 16.1 113 26.3 <.0001
Active infective endocarditis 66 2.9 61 3.3 5 1.1 .0269
Active neoplasm 53 2.4 43 2.4 10 2.3 .9794
Recent myocardial infarction 61 2.7 42 2.3 19 4.4 .0015
Previous PCI 116 5.1 85 4.6 31 7.2 .0356
Logistic euroSCORE 7.2  6.2 5.8  5.0 13.1  7.6 <.0001
Additive euroSCORE 6.3  2.4 5.7  2.1 8.9  1.5 <.0001
NYHA, New York Heart Association; CCS, Canadian Cardiovascular Society; EF, ejection fraction; COPD, chronic obstructive pulmonary disorder; PCI, percutaneous coronary
intervention; euroSCORE, European System for Cardiac Operative Risk Evaluation.
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DPostoperative neurologic complications occurred in 2.2%
of patients (stroke, 1.3%; transient ischemic attack, 0.6%;
and paraplegia, 0.3%). Ventilatory support more than 4
days was required in 3.1% of patients. Postoperative renal
failure occurred in 2.3% of patients, and 0.8% required de-
finitive dialysis. Acute myocardial infarction and bleeding
requiring re-thoracotomy occurred in 0.2% and 3.1% of pa-
tients, respectively. Postoperative atrial fibrillation and
third-degree atrioventricular block were reported in 34.2%
and 2.9% of patients, respectively.Octogenarians
Octogenarians had significantly higher incidence of both
hospital mortality (3.7% vs 1.8%; OR ¼ 2.1; P ¼ .014)
and postoperative complications, such as renal failure
(3.7% vs 2%; P ¼ .045), stroke (2% vs 0.9%; P ¼ .072),
atrial fibrillation (38.6% vs 33.2%; P ¼ .058), and third-
degree atrioventricular block (4.3% vs 2.5%; P ¼ .076).
Length of hospital stay for octogenarians was 15.7  8.2
days versus 14.0  8.5 days for younger patients
(P< .0001).942 The Journal of Thoracic and Cardiovascular SurgOctogenarians With Logistic euroSCORE Greater
Than 15%
A total of 114 patients aged more than 80 years and a lo-
gistic euroSCORE more than 15% (Table 2) had a predicted
risk of hospital mortality of 22.4% (n¼ 26) by logistic euro-
SCORE. The observed mortality was 7.0% (n ¼ 8;
z score ¼3.94; P< .001).
Postoperative complications included stroke (n ¼ 4;
3.1%), ventilatory support more than 4 days (n ¼ 5; 4.1%),
renal insufficiency (n ¼ 7; 6.1%), dialysis (n ¼ 3; 2.6%),
re-thoracotomy for bleeding (n ¼ 4; 3.1%), atrial fibrillation
(n ¼ 44; 39.1%), and third-degree atrioventricular block
(n ¼ 4; 3.1%). Length of hospital stay was 16.7  8.8 days,
with a mean intensive-care length of stay of 3.3  5.0 days.
Mid-Term Results
Estimated survivals at 1 and 3 years were 94.2% and
89.3%, respectively. NYHA III–IV (hazard ratio
[HR] ¼ 1.7; 95% CI, 1.2–2.3), CCS III–IV (HR ¼ 1.8;
95% CI, 1.1–3.3), pulmonary artery pressure greater than
60 mm Hg (HR ¼ 4.1; 95% CI, 1.7–10.1), ejection fraction
30% to 50% (HR ¼ 1.7; 95% CI, 1.2–2.5), age more thanery c April 2011
TABLE 2. Octogenarians with logistic euroSCORE less than and
more than 15%: Patients’ profile
Preoperative variables
euroSCORE
logistic<15%
(N ¼ 316)
euroSCORE
logistic 15%
(N ¼ 114)
P valueN % N %
Female 208 65.8 76 66.7 .8708
Body mass index  30 45 14.2 15 13.2 .7755
Emergency status 0 0.0 3 2.6 .0037
Urgency status 16 5.1 18 15.8 .0003
NYHA ¼ 4 18 5.7 17 14.9 .002
CCS 3 or 4 14 4.4 9 7.9 .1595
Congestive heart failure 22 7.0 16 14.2 .0214
Hemodynamic instability 0 0.0 2 1.8 .0179
Cardiogenic shock 0 0.0 3 2.7 .0036
30%<FE%<50% 36 11.4 24 21.1 .0106
FE  30% 0 0.0 9 7.9 <.0001
Pulmonary artery
pressure>60
1 0.3 5 4.4 .0014
Hypertension 229 72.5 92 80.7 .0836
Diabetes 41 13.0 19 16.7 .3306
Severe COPD 11 3.5 21 18.4 <.0001
Creatinine  2 mg/dL 3 0.9 9 7.9 .0001
Dialysis 0 0.0 0 0.0
Cerebrovascular disease 17 5.4 12 10.5 .0606
Central neurologic
dysfunction
0 0.0 8 7.1 <.0001
Peripheral neurologic
dysfunction
0 0.0 7 6.2 <.0001
Extracardiac vasculopathy 33 10.5 80 70.2 <.0001
Active infective endocarditis 0 0.0 5 4.1 .001
Active neoplasm 5 1.6 5 4.4 .0871
Previous PCI 20 6.2 11 9.8 .2028
euroSCORE, European System for Cardiac Operative Risk Evaluation; NYHA, New
York Heart Association; EF, ejection fraction; COPD, chronic obstructive pulmonary
disorder; CCS, Canadian Cardiovascular Society; PCI, percutaneous coronary inter-
vention.
FIGURE 1. Three-year survival of the overall study population stratified
according to NYHA class I–II and III–IV, and expected survival of age-
and gender-matched 2006 regional population. Survival of patients in class
III–IV is significantly lower than survival of patients in class I–II (log-rank
P<.001) and expected survival. Survival of patients in class I–II is compa-
rable to expected survival of age- and gender-matched 2006 regional pop-
ulation (log-rank P ¼ .1634). NYHA, New York Heart Association.
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95% CI, 3.1–16.7), and cerebrovascular disease (HR¼ 2.4;
95% CI, 1.4–3.9) emerged as independent risk factors for 3-
year survival. The 3-year survival of patients undergoing
surgery in NYHA class I–II was higher than 3-year survival
of patients undergoing surgery in class III–IV (P¼ .157) and
similar to the expectancy of life of the age- and gender-
matched 2006 regional population (P ¼ .163) (Figure 1).
Age greater than 80 years significantly affected mid-term
results with 1- and 3-year survivals of 91.2% and 82.3%, re-
spectively (P< .001) (Figure 2). However, 3-year survival
of octogenarian patients was comparable to the expectancy
of life of the age- and gender-matched 2006 regional popu-
lation (P ¼ .157) (Figure 3).DISCUSSION
As a consequence of ameliorated perioperative care and
increased life expectancy, preoperative characteristics andThe Journal of Thoracic and Carisks and results of aortic valve surgery have been changing
over the last 20 years. Thus, a need for up-to-date outcome
reports associated with identification of predictors of mortal-
ity seems to be evident in our study and others.10-12
In particular, we sought to consider a very select popula-
tion receiving a first-time isolated aortic valve replacement
(excluding redo and combined procedures) and to include
only preoperative variables in the logistic model to optimize
risk stratification and avoid possible confounding factors.
Prospective and contemporary enrollment together withrdiovascular Surgery c Volume 141, Number 4 943
FIGURE 2. Three-year survival of the study population according to
age  80 or<80 years. FIGURE 3. Three-year survival of the octogenarian study population com-
pared with expected survival of age- and gender-matched 2006 regional
population (log-rank P ¼ .157). AVR, Aortic valve replacement.
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demic hospital: n¼ 2; private hospital: n ¼ 4) allowed us to
depict an interesting sample of patients currently referred for
aortic valve replacement.
Our preoperative data confirmed that patients who are
currently referred for aortic valve surgery in most cases
have an aortic stenosis, are elderly, and present severe
comorbidities.4
Despite a mean predicted mortality risk of 7.2% by logis-
tic euroSCORE, the actual mortality was 2.2%, which
favorably compares with that reported by other recent surgi-
cal registries, such as the Society of Thoracic Surgeons
database (2.6%),13 the United Kingdom Cardiac Surgical
Register (3.2%),14 and the Euro Heart Survey (2.7%).4
According to the American College of Cardiology/Amer-
ican Heart Association guidelines for the management of pa-
tients with valvular heart disease, aortic valve replacement is
indicated as class 1 in symptomatic patients with severe aor-
tic valve stenosis and recommended in patients with severe
aortic valve stenosis and impaired left ventricle function.
Valve surgery for asymptomatic patients is considered
only as class IIb, in the presence of positive exercise test,
and likelihood of rapid progression because the risk of944 The Journal of Thoracic and Cardiovascular Surgsudden death in asymptomatic patients (1% per year) is
supposed to be inferior to the risk of death after surgery
and the risk of thromboembolic complication if long-term
anticoagulation therapy has to be initiated.9
Our data showed that hospital mortality for patients in
NYHA class I and I–II was only 0.8% and 1.2%, respec-
tively. The 3-year survival of patients receiving surgery in
NYHA class I–II was better than survival of patients oper-
ated in NYHA class III–IV and similar to the expectancy
of life of the regional age- and gender- matched population.
NYHA class III–IV correlated with both increased risk for
hospital mortality and reduced survival at 3 years.
Taken together, these findings indicate the short- and mid-
term benefits of early referral to surgery for aortic valve
replacement. These considerations also might be extended
to elderly patients because their symptoms are easily under-
estimated and a stress test is difficult to be executed.15
Compared with younger patients, our 430 octogenarians
presented a higher prevalence of cardiac risk factors and
comorbidities, which resulted in a higher hospital mortality
rate. Nevertheless, short and mid-term results wereery c April 2011
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and 3-year survivals of 91.2%, 89.7%, and 82.3%, respec-
tively. On multivariate analysis, age more than 80 years did
not emerge as a risk factor for hospital mortality, whereas, as
expected, it was associated with a decreased 3-year survival
compared with younger age.
Our hospital mortality of 3.2% in octogenarians favor-
ably compares with mortality rates reported by other groups,
ranging from 4.3% to 10.3%.16-20 A different bias in patient
selection is a possible reason for this. On the other hand, it is
plausible that our early results reflect the physiologic
progress of contemporary intraoperative and perioperative
care, which should be considered when referring (and
even more when contraindicating) elderly patients to aortic
valve surgery.
Kolh and colleagues19 reported a 5-year survival of
73.2% in octogenarian patients undergoing aortic valve re-
placement. Sundt and colleagues2 reported a 5-year survival
of 55%, with a quality of life similar to that predicted for the
general population aged more than 75 years. Mihaljevic and
colleagues15 reported that from 2 years after valve replace-
ment, elderly patients have survival similar to that of age,
race, and gender-matched population estimates.
At 3 years, the actuarial survival was 82.3% in our series
and comparable to the expectancy of life of the age- and
gender-matched regional population (P ¼ .157).
All these data indicate that the outcome of octogenarians
after aortic valve replacement is satisfactory in the short and
mid-term. Therefore, aortic valve replacement should not be
denied on the basis of age alone, but rather on the basis of
associated comorbidities and results of the surgical center.
However, the Euro Heart Survey for Valvular Disease in-
dicated that 33% of patients with symptomatic aortic valve
stenosis are considered inoperable because of advanced age
and comorbidities (eg, COPD and renal failure) and are not
referred for surgery.4 Thus, transcatheter techniques for aor-
tic valve implantation have been developed and currently of-
fered as alternative options to patients with perceived high
operative risk.7 Operative risk algorithms, such as the euro-
SCORE, are being used to select patients with prohibitive
risk for conventional aortic valve surgery, and in particular,
a logistic euroSCORE greater than 15% to 20% is consid-
ered as the cutoff value to refer patients to less-invasive trans-
catheter aortic valve procedures.7,8 The accuracy of this risk
model is still questioned and not yet fully validated.3,21-23
Of 2267 patients, we identified 114 patients aged more
than 80 years with a logistic euroSCORE greater than
15% aiming to provide target results to transcatheter aortic
valve procedures and to estimate the effectiveness of logistic
euroSCORE to predict the operative risk of patients under-
going aortic valve surgery. Our results, an expression of
contemporary aortic valve surgery, were extremely encour-
aging. In our series, the mean predicted hospital mortality
was 22% and the observed mortality was 7.0%.The Journal of Thoracic and CaPostoperatively, stroke occurred in 3.1% of patients, respi-
ratory insufficiency occurred in 4.1% of patients, dialysis
occurred in 2.1% of patients, and 3-degree atrioventricular
block occurred in 3.1% of patients.
As reported in the literature, transcatheter aortic valve
procedures are associated with hospital (or 30 days) mortal-
ity rates ranging from 5% to 18%, with a considerable
incidence of postoperative strokes (0%–9%), vascular
complications (10%–15%), and pacemaker implantations
(up to 24%).8
These data lead to the following considerations:
1. The logistic euroSCORE per se is not adequate to pre-
dict the operative risk of elderly patients undergoing
aortic valve replacement. Its central position in the
decision-making process for addressing patients to
transcatheter aortic valve implantation seems to be
hardly defendable.
2. New, more accurate, and calibrated risk-stratification
systems weighting other relevant comorbidities,
such as porcelain aorta, previous chest wall irradia-
tion, liver insufficiency, and poor nutritional status,
are required to provide appropriate indication to trans-
catheter aortic valve implantation.
3. Only prospective randomized clinical trials compar-
ing short and mid-term outcomes from contemporary
aortic valve surgery and transcatheter aortic valve pro-
cedures will fairly estimate the survival and functional
benefits of conventional versus newer aortic valve
procedures.CONCLUSIONS
The outcome after aortic valve replacement was extremely
satisfactory with an overall hospital mortality of 2.2%. The
early referral to aortic valve replacement (NYHA I–II) was
associated with decreased hospital mortality and increased
3-year survival. Octogenarians did well in the short and
mid-term after conventional isolated aortic valve replace-
ment with a hospital mortality of 3.2% and a 3-year survival
of 82.3%. At 3 years, the survival was comparable to the life
expectancy of the age- and gender-matched regional popula-
tion. These results should be taken into consideration when
aortic valve surgery is contraindicated for octogenarians.
New, more accurate and calibrated risk-stratification systems
are required to identify patients who might benefit from
transcatheter aortic valve procedures.
Limitations of the Study
Mid-term results and relative implications were based
on follow-up survival data obtained on regional inhabitants
(80.8%). For these patients, follow-up was 100% com-
pleted. However, no differences in terms of preoperative
risk profile were observed between regional and extra-
regional inhabitants, except that congestive heart failurerdiovascular Surgery c Volume 141, Number 4 945
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in the regional patients. Hospital mortality rates between
the 2 groups were comparable, and surgery in
extra-regional inhabitants was not associated with an in-
creased risk of hospital mortality on multivariate analysis.
The excellent results observed in patients operated in func-
tional class I–II make early surgery a reasonable option. How-
ever, only prospective randomized trials can establish the
superiority of early surgery over conservative management
in asymptomatic patients with severe aortic valve stenosis.
Because of a referral bias, octogenarian patients in our se-
ries may not represent all patients requiring aortic valve sur-
gery in our region. This possible bias of selection may have
affected our patients’ outcome and conclusions. Neverthe-
less, our contemporary series of 430 octogenarians repre-
sents an interesting sample of ‘‘real life’’ in aortic valve
surgery, and our favorable outcome may be applicable to
the current management of elderly patients undergoing
aortic valve replacement.
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APPENDIX 1
Variable Definition
Body mass index kilograms (weight)/meters squared (height)
Hypertension History of hypertension on medication, diet, physical activity; AP>140/90 mm Hg
Diabetes History of diabetes or medication
Dialysis Dialysis at admission
Creatinine milligrams/deciliter
Peripheral neurologic dysfunction Disease severely affecting ambulation and day-to-day function
Central neurologic dysfunction Disease severely affecting ambulation and day-to-day function
Extracardiac vasculopathy Claudication or carotid artery stenosis>50% or previous/scheduled procedure on abdominal aorta, carotid artery,
or limb arteries
Active infective endocarditis Receiving antibiotics
Severe COPD FEV1<50% or PO2<60 or PCO2>50
Cerebrovascular disease Coma>24 h
Cerebrovascular accident>72 h
Transient ischemic attack<24 h
Carotid artery stenosis>50%
Active neoplasm
Congestive heart failure Orthopnea; exertional dyspnea with diuretics and digital; pulmonary venous congestion on chest x-ray
CCS 0–I–II–III–IV
NYHA I–II–III–IV
Hemodynamic instability AP>80 mm Hg or cardiac index>1.8 L/min/m2 with IV inotropic support or IABP
Cardiogenic shock PA<80 mm Hg or Cardiac Index<1.8 L/min/m2 despite inotropic or IABP support
Cardiopulmonary reanimation
Ejection fraction As estimated by echocardiography or angiography
Pulmonary hypertension Systolic pulmonary artery pressure>60 mm Hg as estimated by preoperative catheterization or Swan–Ganz
catheter before surgery
Urgency Surgery performed during the same hospitalization
Emergency Immediate surgery
AP, Arterial pressure; COPD, chronic obstructive pulmonary disorder; FEV1, forced expiratory volume in 1 second; PA, pulmonary artery; IABP, intraaortic balloon pump;
IV, intravenous; CCS, Canadian Cardiovascular Society; NYHA, New York Heart Association.
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